News on Lymphoma continually updated from thousands of sources around the net.
Patients with stage I and II Hodgkin's Disease who receive consolidated radiation therapy have a higher 10-year survival rate of 84 percent, compared to 76 percent for patients who did not receive RT; and, the data also shows a decrease in utilization of RT, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting.
Hundreds of people - many with family or friends who fought or are fighting cancercer - laced up their shoes and joined in the annual Terry Fox Run today. In Winnipeg, Lindsey McKenty said she was thinking of family members who have died of cancer as she ran the five-kilometre course through Assiniboine Park.
Laurie Rizzo knows how fortunate her family was to have the Red Sox help when her son, current Cubs first baseman Anthony Rizzo , was diagnosed with Hodgkin's Lymphoma in 2008. It's why they created the Anthony Rizzo Family Foundation, and why their "Walk off for Cancer" is so important.
WHEN Tara Deacon went to hospital with "the flu", she never thought she and sister Jade would be diagnosed with the same cancer on the same day. Zheng Gang was found dead in a sperm bank after making too many 'donations'.
Monica Stubbs was only 23 when she was diagnosed with Hodgkin lymphoma and had to make a hasty decision about motherhood. But having her eggs frozen was not publicly funded at the time and she could not afford to pay the $9000 to undergo the treatment privately.
A new antifungal drug, isavuconazole, matched the efficacy of voriconazole for treatment of invasive fungal infections in cancer patients with compromised immunity, but with fewer side effects, researchers reported at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy last week in Washington, DC.Isavuconazole was shown to be effective against various fungal infections that act as opportunistic illnesses in people with HIV/AIDS, including Aspergillus , Candida , and Cryptococcus. Isavuconazole is a triazole antifungal being developed by Astellas and Basilea Pharmaceutica International, available in oral and intravenous formulations; it is under evaluation for U.S. Food and Drug Administration approval.
Napa, CA Set to be hosted by ZD Wines and Patrick Dempsey in California's world-renowned Napa Valley on Oct. 18, the inaugural Crush Challenge presented by Amgen is a wine, food and cycling experience benefiting three outstanding charities; the deLeuze Family Endowment for a Non-Toxic Cure for Lymphoma , the Patrick Dempsey Center for Cancer Hope & Healing and Amgen's Breakaway from Cancer . All net revenue from ticket sales and silent auction proceeds will be passed on to these charities to help raise awareness for each cause.
It's not every day a freshman meets the Marple Newtown football team out on the field for their home opener. "They gave us so much love and support and that's what gets us through every day at the hospital," mother Melissa Shelly said.
Friends will gather in Port Moody's Rocky Point Park on Oct. 4 to take part in a Light the Night Memorial Walk. Established by the Leukemia and Lymphoma Society of Canada, the walk will honour the memory of Tanya Aspeleiter, who died of leukemia earlier this year.
Kandi Sahaj, age 36, was recently diagnosed with Hodgkins Lymphoma, stage 2. She attended Camino School when she was younger and now her son Brandon attends. A long-time Camino resident.
We shared the story of Megan Meier earlier this year as she received treatment for Hodgkin's lymphoma. She's now cancer free.
That's good enough to outpace the S&P 500, which has returned just shy of 10%, but not good enough to outperform Celgene's Nasdaq biotechnology index peers, which have returned more than 20%. Since Celgene is one of biotech's biggest companies, generating more than $6 billion in sales and over a billion dollars in annual profit, let's take a look at what's behind Celgene's stock price performance this year.
Shares in the company's stock have returned 40% this year, outpacing both the S&P 500 index's 10% return and the Nasdaq Biotechnology index's 19% return. That's an impressive performance, particularly for a company boasting a market cap of over $160 billion.
AFMD, a clinical-stage biopharmaceutical company, engaged in the development of cancer immunotherapies, plans to raise $75 million in its upcoming IPO, set to price Thursday night. AFMD is still far from commercializing of its products; however, we suspect the firm's successful early trial results for AFM13 will attract investor interest.
The Leukemia & Lymphoma Society Northern California Light The Night Walk Campaign To Kick Off With San Francisco Walk At AT&T Park /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's Northern California Chapter will be kicking off its 2014 Light The NightA Walk campaign with the San Francisco Walk on at AT&T Park. The Light The Night Walk is a powerful and unique fundraising campaign from LLS, which brings together families and communities to honor blood cancer survivors and loved ones lost to the disease.
Updated: Mon Sep 15, 2014 12:10 am
Copyright © 2014 Topix LLC